Clinical Trials in North Carolina

Showing 18261-18280 of 20,428 trials

A Trial of TT223 in Patients With Type 2 Diabetes Who Are Taking Metformin and/or Thiazolidinedione

NCT00743002

This trial is designed to show the effect of treatment with TT223 or placebo on blood glucose control after 12 weeks of treatment with a 6 month follow-up. TT223 is administered by injection once daily to patients currently treated with Metformin and/or Thiazolidinedione.

Diabetes Mellitus, Type 2

OPKO Health, Inc.87 participantsStarted Aug 2008

Artesia, California, United States • Los Angeles, California, United States • Santa Ana, California, United States +17 more locations

COMPLETEDPhase 241 miles

Interferon Alfa and Thalidomide in Treating Patients With Stage IV Melanoma

NCT00026520

RATIONALE: Interferon alfa may interfere with the growth of cancer cells and slow the growth of the tumor. Thalidomide may stop the growth of cancer by stopping blood flow to the tumor. Combining interferon alfa with thalidomide may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of combining interferon alfa with thalidomide in treating patients who have stage IV melanoma.

Melanoma (Skin)

SWOG Cancer Research NetworkStarted Nov 2001

Mobile, Alabama, United States • Phoenix, Arizona, United States • Phoenix, Arizona, United States +91 more locations

A Trial of TT223 in Patients With Type 2 Diabetes Who Are Taking Metformin and/or Thiazolidinedione

Interferon Alfa and Thalidomide in Treating Patients With Stage IV Melanoma

Find Trials by Condition in North Carolina

Radiation Therapy With or Without SU5416 in Treating Patients With Soft Tissue Sarcoma

Gefitinib in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer or Primary Peritoneal Cancer

Erlotinib in Treating Patients With Locally Advanced or Metastatic Stomach Cancer or Gastroesophageal Junction Cancer

Irinotecan in Treating Patients With Recurrent Malignant Glioma

Efaproxiral Plus Carmustine in Treating Patients With Progressive or Recurrent Malignant Glioma

Oxaliplatin in Treating Patients With Recurrent or Refractory Cervical Cancer

A Study of Sativex® for Pain Relief in Patients With Advanced Malignancy.

Paclitaxel in Treating Patients With Advanced, Refractory, or Recurrent Cervical or Vaginal Cancer

Centralized Cord Blood Registry to Facilitate Unrelated Cord Blood Transplantation

Voriconazole in Preventing Fungal Infections in Children With Neutropenia After Chemotherapy

Anidulafungin in Treating Immunocompromised Children With Neutropenia

Study to Evaluate the Safety and Efficacy of Inhaled PT001 in Patients With Chronic Obstructive Pulmonary Disease (COPD)

National Inferior Vena Cava (IVC) Filter Registry

The CANTATA-MSU Trial (CANagliflozin Treatment And Trial Analysis - Metformin and SUlphonylurea)

Combination Chemotherapy Plus Bevacizumab in Treating Patients With Advanced Colorectal Cancer

Trastuzumab Plus Chemotherapy in Treating Patients With Advanced Non-small Cell Lung Cancer

506U78 in Treating Patients With Relapsed or Refractory T-cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma

Interleukin-12 in Treating Patients With Advanced or Recurrent Cancer of the Cervix